Evidence map›Paper›PMID 36038669›Full record

GuidelineStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2022

DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.

Denise Bernhardt, Laila König, Anca Grosu, Benedikt Wiestler, Stefan Rieken, Wolfgang Wick, Jens Gempt, Sandro M Krieg, Friederike Schmidt-Graf, Felix Sahm and 13 more

Abstract readReviewPractice Guideline
In one paragraph

Guideline in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Guideline
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Resolving spatial response heterogeneity in glioblastoma.European journal of nuclear medicine and molecular imaging · 2024
    Article
  19. Effect of different optimization parameters in single isocenter multiple brain metastases radiosurgery.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Denise BernhardtKlinik und Poliklinik für Radioonkologie und Strahlentherapie, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Germany. denise.bernhardt@mri.tum.de.ORCID http://orcid.org/0000-0001-5231-9097
Laila KönigKlinik für Radioonkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Anca GrosuPartner Sites Munich, Freiburg and Heidelberg, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Heidelberg, Germany.
Benedikt WiestlerDepartment of Neuroradiology, School of Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Stefan RiekenClinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Wolfgang WickClinical Cooperation Unit Neurooncology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jens GemptDepartment of Neurosurgery, School of Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Sandro M KriegDepartment of Neurosurgery, School of Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Friederike Schmidt-GrafDepartment of Neurology, School of Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Felix SahmDepartment of Neuropathology, University Hospital Heidelberg and CCU Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Bernhard MeyerDepartment of Neurosurgery, School of Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.
Bernd J KrauseDepartment of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany.
Cordula PetersenDepartment of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Rainer FietkauDepartment of Radiation Oncology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Michael ThomasDepartment of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Heidelberg, Germany.
Frank GiordanoDepartment of Radiation Oncology, University Hospital Bonn, Bonn, Germany.
Andrea Wittig-SauerweinDepartment of Radiotherapy and Radiation Oncology, University Hospital Jena, Bachstr. 18, 07743, Jena, Germany.
Jürgen DebusPartner Sites Munich, Freiburg and Heidelberg, Deutsches Konsortium für Translationale Krebsforschung (DKTK), Heidelberg, Germany.
Ghazaleh TabatabaiDepartment of Neurosurgery, University Hospital Tuebingen, Eberhard Karls University Tuebingen, Tuebingen, Germany.
Peter HauWilhelm Sander-NeuroOncology Unit and Department of Neurology, University Hospital Regensburg, 93053, Regensburg, Germany.
Joachim SteinbachDr Senckenberg Institute of Neurooncology, University Hospital, Frankfurt am Main, Germany.
Stephanie E CombsKlinik und Poliklinik für Radioonkologie und Strahlentherapie, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Germany.
Expert Panel of the German Society of Radiation Oncology (DEGRO)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe Working Group for Neuro-Oncology of the German Society for Radiation Oncology in cooperation with members of the Neuro-Oncology Working Group of the German Cancer Society aimed to define a practical guideline for the diagnosis and treatment of radiation-induced necrosis (RN) of the central nervous system (CNS).

methodsPanel members of the DEGRO working group invited experts, participated in a series of conferences, supplemented their clinical experience, performed a literature review, and formulated recommendations for medical treatment of RN including bevacizumab in clinical routine.

conclusionDiagnosis and treatment of RN requires multidisciplinary structures of care and defined processes. Diagnosis has to be made on an interdisciplinary level with the joint knowledge of a neuroradiologist, radiation oncologist, neurosurgeon, neuropathologist, and neuro-oncologist. A multistep approach as an opportunity to review as many characteristics as possible to improve diagnostic confidence is recommended. Additional information about radiotherapy (RT) techniques is crucial for the diagnosis of RN. Misdiagnosis of untreated and progressive RN can lead to severe neurological deficits. In this practice guideline, we propose a detailed nomenclature of treatment-related changes and a multistep approach for their diagnosis.

Indexed as

Radiation InjuriesRadiation OncologyBevacizumabCentral Nervous SystemHumansNecrosisBevacizumabBevacizumabBrain metastasesGliomaRadioation necrosisReirradiation

Identifiers

PMID36038669
PMCPMC9515024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.